FR2857362B1 - Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation - Google Patents

Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation

Info

Publication number
FR2857362B1
FR2857362B1 FR0308441A FR0308441A FR2857362B1 FR 2857362 B1 FR2857362 B1 FR 2857362B1 FR 0308441 A FR0308441 A FR 0308441A FR 0308441 A FR0308441 A FR 0308441A FR 2857362 B1 FR2857362 B1 FR 2857362B1
Authority
FR
France
Prior art keywords
pyrazolo
pyridines
compositions containing
containing same
substituted tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0308441A
Other languages
English (en)
Other versions
FR2857362A1 (fr
Inventor
Fabienne Thompson
Patrick Mailliet
Teresa Damiano
Marie Pierre Cherrier
Francois Clerc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0308441A priority Critical patent/FR2857362B1/fr
Priority to ARP040102391A priority patent/AR045037A1/es
Priority to AU2004256945A priority patent/AU2004256945B2/en
Priority to BRPI0412411-1A priority patent/BRPI0412411A/pt
Priority to JP2006518294A priority patent/JP4740841B2/ja
Priority to CA002532122A priority patent/CA2532122A1/fr
Priority to KR1020067000505A priority patent/KR20060054291A/ko
Priority to EP10173683A priority patent/EP2251340A1/fr
Priority to MXPA06000247A priority patent/MXPA06000247A/es
Priority to EP04767613A priority patent/EP1646632A2/fr
Priority to PCT/FR2004/001778 priority patent/WO2005007653A2/fr
Priority to US10/888,611 priority patent/US7109340B2/en
Priority to TW093120534A priority patent/TW200519110A/zh
Publication of FR2857362A1 publication Critical patent/FR2857362A1/fr
Application granted granted Critical
Publication of FR2857362B1 publication Critical patent/FR2857362B1/fr
Priority to IL172994A priority patent/IL172994A0/en
Priority to US11/419,794 priority patent/US7435820B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0308441A 2003-07-10 2003-07-10 Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation Expired - Fee Related FR2857362B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR0308441A FR2857362B1 (fr) 2003-07-10 2003-07-10 Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation
ARP040102391A AR045037A1 (es) 2003-07-10 2004-07-07 Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
EP04767613A EP1646632A2 (fr) 2003-07-10 2004-07-08 Tetrahydro-1h-pyrazolo¬3,4-c|pyridines substituees, compositions pharmaceutiques les contenant et utilisation pour le traitement du cancer
JP2006518294A JP4740841B2 (ja) 2003-07-10 2004-07-08 置換テトラヒドロ−１Ｈ−ピラゾロ［３，４−ｃ］ピリジン、それらを含む組成物、及び使用
CA002532122A CA2532122A1 (fr) 2003-07-10 2004-07-08 Tetrahydro-1h-pyrazolo[3,4-c]pyridines substituees, compositions les contenant et utilisation
KR1020067000505A KR20060054291A (ko) 2003-07-10 2004-07-08 치환된 테트라하이드로-1Ｈ-피라졸로[3,4-ｃ]피리딘, 이를 함유하는 조성물 및 이의 용도
EP10173683A EP2251340A1 (fr) 2003-07-10 2004-07-08 Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation
MXPA06000247A MXPA06000247A (es) 2003-07-10 2004-07-08 Tetrahidro-1h-pirazolo[3,4-c]piridinas sustituidas composiciones que las contienen y su utilizacion.
AU2004256945A AU2004256945B2 (en) 2003-07-10 2004-07-08 Substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, compositions containing same and use
PCT/FR2004/001778 WO2005007653A2 (fr) 2003-07-10 2004-07-08 Tetrahydro-1h-pyrazolo[3,4-c]pyridines substituees, compositions les contenant et utilisation
BRPI0412411-1A BRPI0412411A (pt) 2003-07-10 2004-07-08 tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
US10/888,611 US7109340B2 (en) 2003-07-10 2004-07-09 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use
TW093120534A TW200519110A (en) 2003-07-10 2004-07-09 Substituted tetrahydro-1H-pyrazolo [3, 4-c] pyridines, compositions comprising them, and use
IL172994A IL172994A0 (en) 2003-07-10 2006-01-05 Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing them, and use
US11/419,794 US7435820B2 (en) 2003-07-10 2006-05-23 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0308441A FR2857362B1 (fr) 2003-07-10 2003-07-10 Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation

Publications (2)

Publication Number Publication Date
FR2857362A1 FR2857362A1 (fr) 2005-01-14
FR2857362B1 true FR2857362B1 (fr) 2005-09-23

Family

ID=33522928

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0308441A Expired - Fee Related FR2857362B1 (fr) 2003-07-10 2003-07-10 Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation

Country Status (1)

Country Link
FR (1) FR2857362B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254911A1 (en) * 2006-03-27 2007-11-01 Mingde Xia Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827861B1 (fr) * 2001-07-27 2004-04-02 Aventis Pharma Sa Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie
MXPA04002243A (es) * 2001-09-19 2004-06-29 Aventis Pharma Sa Compuestos quimicos.

Also Published As

Publication number Publication date
FR2857362A1 (fr) 2005-01-14

Similar Documents

Publication Publication Date Title
IL172994A0 (en) Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing them, and use
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2848115B1 (fr) Composition de bacteries et son utilisation
FR2843023B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
HK1093339A1 (en) Aryl-heteroaromatic products, compositions containing same and use thereof
FR2777892B1 (fr) Derive de 1-alcoxy-polyalkyl-piperidine, composition polymerisable le contenant et son utilisation
ITMI991478A0 (it) Composizione pesticida che contiene emamectin
IL169336A0 (en) Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
ZA200702226B (en) Compounds, compositions containing them, preparations thereof and uses thereof II
ATE300177T1 (de) Pestizide zusammensetzung
DE60214035D1 (de) Olefinisches thermoplastisches elastomer, verfahren zu seiner herstellung, olefinisches thermoplastisches elastomer enthaltende zusammensetzungen, verfahren zu ihrer herstellung und formkörper daraus
FR2857363B1 (fr) 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
DE975695T1 (de) Zusammensetzungen, enthaltend gleit- und antiblockmittel
IL169337A0 (en) Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
DZ3424A1 (fr) Composition pesticide
DE60114039D1 (de) Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
FR2784381B1 (fr) Compose fongicide, composition le contenant et son utilisation
FR2857362B1 (fr) Tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees, compositions les contenant et utilisation
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
NO20024880D0 (no) Sammensetning inneholdende fosfat
DE60302781D1 (de) Hydrolysebeständige zusammensetzungen aus polyesterelastomeren, daraus hergestellte artikel und verfahren
MA27351A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR2796382B1 (fr) Organopolysiloxanes modifies, leur preparation, et compositions en contenant
FR2833004B1 (fr) Aryl-cycloalcaines substitues, compositions les contenant et utilisation

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

ST Notification of lapse

Effective date: 20170331